Publication: Haematological effects of oral administration of bitopertin, a glycine transport inhibitor, in patients with non-transfusion-dependent β-thalassaemia
dc.contributor.author | Ali T. Taher | en_US |
dc.contributor.author | Vip Viprakasit | en_US |
dc.contributor.author | Maria Domenica Cappellini | en_US |
dc.contributor.author | Dominik Kraus | en_US |
dc.contributor.author | Patrick Cech | en_US |
dc.contributor.author | Dietmar Volz | en_US |
dc.contributor.author | Erica Winter | en_US |
dc.contributor.author | Stephane Nave | en_US |
dc.contributor.author | Juergen Dukart | en_US |
dc.contributor.author | Omar Khwaja | en_US |
dc.contributor.author | Annette Koerner | en_US |
dc.contributor.author | Ricardo Hermosilla | en_US |
dc.contributor.author | Carlo Brugnara | en_US |
dc.contributor.other | American University of Beirut Medical Center | en_US |
dc.contributor.other | Children's Hospital Boston | en_US |
dc.contributor.other | Università degli Studi di Milano | en_US |
dc.contributor.other | Heinrich-Heine-Universität Düsseldorf | en_US |
dc.contributor.other | Mahidol University | en_US |
dc.contributor.other | F. Hoffmann-La Roche AG | en_US |
dc.contributor.other | Forschungszentrum Jülich (FZJ) | en_US |
dc.contributor.other | Harvard Medical School | en_US |
dc.contributor.other | Roche Innovation Center New York | en_US |
dc.date.accessioned | 2022-08-04T09:20:22Z | |
dc.date.available | 2022-08-04T09:20:22Z | |
dc.date.issued | 2021-07-01 | en_US |
dc.identifier.citation | British Journal of Haematology. Vol.194, No.2 (2021), 474-477 | en_US |
dc.identifier.doi | 10.1111/bjh.17479 | en_US |
dc.identifier.issn | 13652141 | en_US |
dc.identifier.issn | 00071048 | en_US |
dc.identifier.other | 2-s2.0-85105232948 | en_US |
dc.identifier.uri | https://repository.li.mahidol.ac.th/handle/20.500.14594/78098 | |
dc.rights | Mahidol University | en_US |
dc.rights.holder | SCOPUS | en_US |
dc.source.uri | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85105232948&origin=inward | en_US |
dc.subject | Medicine | en_US |
dc.title | Haematological effects of oral administration of bitopertin, a glycine transport inhibitor, in patients with non-transfusion-dependent β-thalassaemia | en_US |
dc.type | Letter | en_US |
dspace.entity.type | Publication | |
mu.datasource.scopus | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85105232948&origin=inward | en_US |